Paper975067
Fundamental carcinogenic processes and their implications for low dose risk assessment.
Crump KS and 3 others. Cancer Res, 1976. Cited by 287 papers, by iCite.
Cite this record
ConductScience Library. Fundamental carcinogenic processes and their implications for low dose risk assessment. Papers, record 975067. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/975067
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinogens, Environmental | Major topic |
| Models, Biological | Major topic |
| Neoplasms | Major topic |
| Dose-Response Relationship, Drug | |
| Mathematics | |
| Risk | |
| Time Factors |
Source PubMed
Cited by71
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 287 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41606603 | The assumption of a threshold is false in risk assessments for endocrine disrupting chemicals (EDCs) when endogenous hormones being disrupted are already above any possible threshold: a policy failure by the US FDA. | Environ Health | 2026 | https://conductscience.org/library/papers/41606603 | PubMed |
| 41531509 | Design, synthesis, and multi-target anticancer evaluation of 1,3-thiazolodin-4-one analogues against breast cancer: mechanistic insights into estrogen metabolism, inflammation, angiogenesis, and oxidative stress. | RSC Adv | 2026 | https://conductscience.org/library/papers/41531509 | PubMed |
| 40519680 | Exploration of the anticancer efficacy of a novel 1,3-thiazole analog in an ehrlich ascites carcinoma model: in vivo and in silico insights into hepatorenal protective potentials via the modulation of apoptosis, oxidative stress and inflammation. | RSC Adv | 2025 | https://conductscience.org/library/papers/40519680 | PubMed |
| 40379996 | Health impacts of exposure to synthetic chemicals in food. | Nat Med | 2025 | https://conductscience.org/library/papers/40379996 | PubMed |
| 39991549 | Dose-dependent association between physical activity and mental health, and mitigation effects on risk behaviors. | iScience | 2025 | https://conductscience.org/library/papers/39991549 | PubMed |
| 39143408 | Formulation and Validation of an Extended Sigmoid Emax Model in Pharmacodynamics. | Pharm Res | 2024 | https://conductscience.org/library/papers/39143408 | PubMed |
| 38812700 | Tradescantia response to air and soil pollution, stamen hair cells dataset and ANN color classification. | Front Big Data | 2024 | https://conductscience.org/library/papers/38812700 | PubMed |
| 38406308 | The effect of age and resilience on the dose-response function between the number of adversity factors and subjective well-being. | Front Psychol | 2024 | https://conductscience.org/library/papers/38406308 | PubMed |
| 38093135 | Molecular Docking and In Vivo Biological Studies of Sodium Salt of 3-(4-Methyl-2-oxo-2-H-quinoline-7-yloxy)-3-phenylacrylic Acid As Anticancer Agent. | Dokl Biochem Biophys | 2023 | https://conductscience.org/library/papers/38093135 | PubMed |
| 35509348 | Group-Based and Individually Delivered LiFE: Content Evaluation and Predictors of Training Response - A Dose-Response Analysis. | Clin Interv Aging | 2022 | https://conductscience.org/library/papers/35509348 | PubMed |
| 32122363 | Impacts of food contact chemicals on human health: a consensus statement. | Environ Health | 2020 | https://conductscience.org/library/papers/32122363 | PubMed |
| 31623196 | Association of Nicotine with Osteochondrogenesis and Osteoarthritis Development: The State of the Art of Preclinical Research. | J Clin Med | 2019 | https://conductscience.org/library/papers/31623196 | PubMed |
| 30963050 | Studies on the effect of a nutritious vegetable, Telfairia occidentalis, on HbSS blood. | J Tradit Complement Med | 2019 | https://conductscience.org/library/papers/30963050 | PubMed |
| 30783394 | When Risk Assessment Came to Washington: A Look Back. | Dose Response | 2019 | https://conductscience.org/library/papers/30783394 | PubMed |
| 30768598 | A general dose-response relationship for chronic chemical and other health stressors and mixtures based on an emergent illness severity model. | PLoS One | 2019 | https://conductscience.org/library/papers/30768598 | PubMed |
| 30574027 | Cancer Risk Assessment and the Biostatistical Revolution of the 1970s-A Reflection. | Dose Response | 2018 | https://conductscience.org/library/papers/30574027 | PubMed |
| 30405051 | Anti-Cancer Drug Sensitivity Assay with Quantitative Heterogeneity Testing Using Single-Cell Raman Spectroscopy. | Molecules | 2018 | https://conductscience.org/library/papers/30405051 | PubMed |
| 30302069 | Quantitative Risk Assessment in the 1970s: A Personal Remembrance. | Dose Response | 2018 | https://conductscience.org/library/papers/30302069 | PubMed |
| 29634771 | Chronic hepatitis B virus and liver fibrosis: A mathematical model. | PLoS One | 2018 | https://conductscience.org/library/papers/29634771 | PubMed |
| 28793913 | The hazards of hazard identification in environmental epidemiology. | Environ Health | 2017 | https://conductscience.org/library/papers/28793913 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/975067
GET https://conductscience.org/api/papers/v1/975067/cited_by?page=2